India's government said on Thursday it has inked a deal with domestic vaccine maker Biological-E for 300 million COVID-19 vaccine doses for 15 billion rupees ($205.62 million), the first such order for unapproved shots.
The vaccine, which is currently undergoing phase-3 clinical trials, is likely to be available in the next few months, the health ministry said in a statement.
Biological E., which also has a separate deal to produce about 600 million doses of Johnson & Johnson's COVID-19 shot annually, said on Tuesday it entered into a licensing agreement with Providence Therapeutics Holdings to manufacture the Canadian company's mRNA COVID-19 vaccine in India.
Biological-E will run a clinical trial of Providence's vaccine in India and seek emergency use approval.
India has suffered a disastrous second wave of infections that is only now abating. Health experts say India needs to carry out mass vaccination of its 1.3 billion people to reduce the impact of subsequent waves.
Prime Minister Narendra Modi's government has drawn criticism for a slow vaccine rollout even though India is one of the world's biggest manufacturers of doses.
Earlier in May, Biological-E Managing Director Mahima Datla had told Reuters that the company plans producing 75 million to 80 million doses a month from August.
Israel bombarded northern Gaza overnight in some of the heaviest shelling in weeks, causing panic amongst residents and flattening neighbourhoods in an area from which the Israeli army had previously down its troops, residents said on Tuesday.
Russia launched a drone attack on Ukraine that injured seven people in the Black Sea port of Odesa, two of them children, and also targeted Kyiv, the capital, Ukraine's military officials said early on Tuesday.
A Delhi court on Tuesday extended the pre-trial detention of Indian opposition leader Arvind Kejriwal until May 7 in a corruption case, the legal news website Live Law reported.
Taiwan's quake-hit eastern county of Hualien was rattled by more than 200 aftershocks late on Monday and early on Tuesday, but only minor damage was reported and no casualties and major chipmaker TSMC said it saw no impact on operations.
Two Malaysian navy helicopters collided in mid-air during a rehearsal for a naval parade on Tuesday, killing all 10 crew members aboard, the navy said in a statement.